Brain Tumor

Identify the molecular signals that control normal brain development and the abnormal signals that drive brain tumors.

The goal of the Leuthardt Lab is to understand brain computer interface (BCI) devices and their implications regarding patient care.

The Molecular Neuro-oncology lab is focused on developing genomic and epigenomic liquid biopsy approaches for non-invasive detection of brain tumors.

Developing high-throughput technologies to study cell-cell interactions. Decoding the metastatic tumor microenvironment. Identifying therapeutic targets in cancer-stroma interactions to fight metastatic cancer.

The YE Li Lab investigates both the genetic and epigenetic contributions to human diseases, particularly in brain tumors and neuropsychiatric disorders.